Support for the DOPPS Program

The Dialysis Outcomes and Practice Patterns Study (DOPPS) Program is funded by a consortium of private industry, public funders, and professional societies, with the shared mission of providing a strong scientific basis for the identification of dialysis and CKD practices that are most associated with improved patient survival and quality of life. Since starting in 1996, the base of funding has expanded to include grants from over 15 funders to support different facets of the collection, analysis, and dissemination of this important information.

Arbor Research Collaborative for Health recognizes supporters for their generous contributions to the DOPPS Program. Such support enables us to continue our mission to identify best practices for improving patient care, and disseminate this important information to the medical community and others in the renal industry. Arbor Research and our DOPPS collaborators gratefully acknowledge the generous support from sponsors, and their strong commitment to independent scientific research for improved patient care.

  • Amgen Inc (since 1996, founding sponsor)
  • AstraZeneca Pharmaceuticals LP (since 2018)
  • Baxter Healthcare Corp (since 2011)
  • European Renal Association-European Dialysis & Transplant Association (ERA-EDTA)
  • Fresenius Medical Care Asia-Pacific Ltd
  • Fresenius Medical Care Canada Inc
  • German Society of Nephrology (Deutsche Gesellschaft für Nephrologie -- DGfN)
  • Italian Society of Nephrology (SIN)
  • Janssen Pharmaceuticals Inc
  • Japanese Society for Peritoneal Dialysis (JSPD)
  • Keryx Biopharmaceuticals, Inc
  • Kidney Care UK
  • Kyowa Hakko Kirin Co., Ltd (since 1999 for Japan DOPPS)
  • MEDICE Arzneimittel Pütter GmbH & Co KG
  • Otsuka America Pharmaceutical, Inc
  • Proteon Therapeutics, Inc
  • Vifor-Fresenius Medical Care Renal Pharma Ltd (since 2011)

 

Public funding and support is provided for specific DOPPS projects, ancillary studies, or affiliated research projects by: 
 
  • Australia: National Health & Medical Research Council (NHMRC) 
  • Canada: Cancer Care Ontario (CCO) through the Ontario Renal Network (ORN)
  • France: French National Institute of Health and Medical Research (INSERM)
  • Thailand: Thailand Research Foundation (TRF), Chulalongkorn University Matching Fund, King Chulalongkorn Memorial Hospital Matching Fund, and the National Research Council of Thailand (NRCT) 
  • United Kingdom: National Institute for Health Research (NIHR) via the Comprehensive Clinical Research Network (CCRN) 
  • United States: National Institutes of Health (NIH)

 

All support is provided without restrictions on publications.

 

Last updated 5/17/2018